Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PROCTER & GAMBLE HEALTH BIOCON /
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 19.7 34.4 57.2% View Chart
P/BV x 1.8 10.5 17.2% View Chart
Dividend Yield % 0.6 2.0 28.1%  

Financials

 BIOCON    PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    BIOCON
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
BIOCON /
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3885,366 7.2%   
Low Rs1923,883 4.9%   
Sales per share (Unadj.) Rs93.1740.7 12.6%  
Earnings per share (Unadj.) Rs5.4138.2 3.9%  
Cash flow per share (Unadj.) Rs14.6155.2 9.4%  
Dividends per share (Unadj.) Rs1.5095.00 1.6%  
Avg Dividend yield %0.52.1 25.2%  
Book value per share (Unadj.) Rs146.5447.6 32.7%  
Shares outstanding (eoy) m1,200.6016.60 7,232.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.16.2 49.9%   
Avg P/E ratio x54.133.5 161.7%  
P/CF ratio (eoy) x19.829.8 66.5%  
Price / Book Value ratio x2.010.3 19.1%  
Dividend payout %28.068.7 40.8%   
Avg Mkt Cap Rs m347,81476,761 453.1%   
No. of employees `000NANA-   
Total wages/salary Rs m21,8102,062 1,057.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,74212,296 908.8%  
Other income Rs m7,681184 4,176.7%   
Total revenues Rs m119,42312,480 956.9%   
Gross profit Rs m16,6113,247 511.6%  
Depreciation Rs m11,131281 3,961.2%   
Interest Rs m4,1908 54,415.6%   
Profit before tax Rs m8,9713,142 285.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,541847 299.9%   
Profit after tax Rs m6,4302,295 280.2%  
Gross profit margin %14.926.4 56.3%  
Effective tax rate %28.327.0 105.0%   
Net profit margin %5.818.7 30.8%  
BALANCE SHEET DATA
Current assets Rs m123,34011,713 1,053.0%   
Current liabilities Rs m85,1076,791 1,253.3%   
Net working cap to sales %34.240.0 85.5%  
Current ratio x1.41.7 84.0%  
Inventory Days Days129263 49.1%  
Debtors Days Days117343 34.0%  
Net fixed assets Rs m394,07810,617 3,711.8%   
Share capital Rs m6,003166 3,616.3%   
"Free" reserves Rs m169,9267,265 2,339.1%   
Net worth Rs m175,9297,431 2,367.7%   
Long term debt Rs m152,9050-   
Total assets Rs m517,41822,330 2,317.2%  
Interest coverage x3.1409.1 0.8%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.20.6 39.2%   
Return on assets %2.110.3 19.9%  
Return on equity %3.730.9 11.8%  
Return on capital %4.042.4 9.4%  
Exports to sales %3.10-   
Imports to sales %6.013.1 45.6%   
Exports (fob) Rs m3,467NA-   
Imports (cif) Rs m6,6541,605 414.5%   
Fx inflow Rs m3,4671,465 236.6%   
Fx outflow Rs m6,6541,605 414.5%   
Net fx Rs m-3,187-140 2,273.2%   
CASH FLOW
From Operations Rs m18,5252,360 785.0%  
From Investments Rs m-142,818-215 66,427.0%  
From Financial Activity Rs m130,487-985 -13,251.4%  
Net Cashflow Rs m6,4111,160 552.5%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.3 51.8 39.1%  
Indian inst/Mut Fund % 21.1 20.3 103.9%  
FIIs % 6.6 7.6 86.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 48.2 81.7%  
Shareholders   434,339 56,730 765.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Procter & Gamble Health Share Price Performance

Period Biocon Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 3.04% -0.69% 1.18%
1-Month -2.42% -7.59% -0.75%
1-Year 30.66% -3.15% 61.82%
3-Year CAGR -13.51% -9.16% 18.16%
5-Year CAGR -2.70% 5.72% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Biocon, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.